Allianz Asset Management Gmb H Deciphera Pharmaceuticals, Inc. Transaction History

Allianz Asset Management Gmb H

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.7 - $37.13 $862,484 - $4.16 Million	-112,011 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$26.46 - $37.15 $91,234 - $128,093	-3,448 Reduced 2.99%	112,011 $3.81 Million
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $136,876 - $200,526	-4,182 Reduced 3.5%	115,459 $4.23 Million
Q1 2021 May 13, 2021	BUY	$40.39 - $56.73 $1.02 Million - $1.43 Million	25,225 Added 26.72%	119,641 $5.37 Million
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $603,845 - $771,923	11,664 Added 14.1%	94,416 $5.39 Million
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $260,566 - $345,993	-5,949 Reduced 6.71%	82,752 $4.25 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $222,744 - $390,960	6,012 Added 7.27%	88,701 $5.3 Million
Q1 2020 May 14, 2020	BUY	$33.63 - $69.4 $974,530 - $2.01 Million	28,978 Added 53.95%	82,689 $3.41 Million
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $1.2 Million - $2.64 Million	37,771 Added 236.96%	53,711 $3.34 Million
Q3 2019 Nov 13, 2019	SELL	$19.95 - $38.85 $12,987 - $25,291	-651 Reduced 3.92%	15,940 $534,000
Q2 2019 Aug 08, 2019	BUY	$21.05 - $26.21 $349,240 - $434,850	16,591 New	16,591 $374,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.